Executive Werner Baumann News Today

By Cecilia Butini Bayer on Thursday posted a fall first-quarter earnings, which the company said were weighed by an impairment loss due to reduced market price expectations on the herbicide... | May 11, 2023

German pharmaceuticals and agriculture group Bayer on Monday confirmed its 2023 sales and earnings guidance and reiterated that business would not really pick up before the second half of the... | April 24, 2023

Bayer warned operating earnings would decline in 2023, adding to the challenges for its new CEO who will take the helm in June, as the agriculture and healthcare company is hit by higher costs and

Agriculture and healthcare company Bayer said operating earnings would likely decline in 2023, hurt by higher costs and the reversal of last years price boost for its glyphosate-based weedkillers.

FRANKFURT (Reuters) - Activist investment fund Inclusive Capital Partners, run by hedge fund veteran Jeffrey Ubben, said on Monday it had acquired a 0...

By Reuters Staff 1 Min Read DUSSELDORF, Feb 15 (Reuters) - German drugmaker Bayer said on Monday it aims to deliver the first doses of CureVac’s COVID-19 vaccine from its factory in Wuppertal in Germany in the fourth quarter. “We are very confident that we will even be able to deliver the first vaccines before the end of the year, if all goes well,” Chief Executive Werner Baumann said during a visit to the plant by the premier of North Rhine-Westphalia Armin Laschet. Head of pharma Stefan...